As of 2025-11-05, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (23.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -223.9%.
The range of the Relative Valuation is (22.05) - (24.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 16.7x | 13.7x |
| Forward P/E multiples | 15.0x - 23.6x | 18.2x |
| Fair Price | (22.05) - (24.67) | (23.54) |
| Upside | -216.0% - -229.8% | -223.9% |
| Date | P/E |